Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may spot hidden gallbladder cancer in gallstone patients

NCT ID NCT07744477

Completed Diagnosis Sponsor: Centre Paul Strauss Source: ClinicalTrials.gov ↗

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study looks at whether ten specific substances in the blood can help tell apart patients with gallbladder cancer from those with only gallstone disease. Researchers will measure these markers in a new group of Chilean patients to confirm earlier findings. If the markers prove reliable, they might one day be used as a simple blood test to catch gallbladder cancer earlier.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
serum samples
What this could lead to
If validated, these blood markers could lead to a simple blood test to help detect gallbladder cancer earlier in people with gallstones.
What could go wrong
This is a validation study, so the markers may not hold up in a larger, independent group. Also, the findings may not apply to patients outside South America.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GALLBLADDER MALIGNANT NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cholelithiasis gallbladder cancer gallbladder neoplasm gallstones

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GALLBLADDER MALIGNANT NEOPLASM GALLSTONE DISEASE

Contacts and locations

Locations

  • Clínica Alemana de Santiago

    Santiago, Chile

  • Clínica Alemana de Temuco

    Temuco, Chile

  • Clínica Monte Sinaí

    Juliaca, Peru

  • Complejo Asistencial Padre Las Casas

    Temuco, Chile

  • Complejo Hospitalario Viedma

    Cochabamba, Bolivia

  • Fundación Arturo López Perez (FALP)

    Santiago, Chile

  • Hospital Barros Luco

    Santiago, Chile

  • Hospital Base III- La Capilla ESSALUD

    Juliaca, Peru

  • Hospital Clínico Universidad de Chile

    Santiago, Chile

  • Hospital Clínico de Magallanes

    Arica, Chile

  • Hospital De Puerto Montt

    Port Montt, Chile

  • Hospital El Pino

    Santiago, Chile

  • Hospital Goyoneche

    Arequipa, Peru

  • Hospital Honorio Delgado

    Arequipa, Peru

  • Hospital Obrero No. 2 (Caja Nacional del Seguro Social)

    Cochabamba, Bolivia

  • Hospital Padre Hurtado

    Santiago, Chile

  • Hospital Regional Manuel Nuñez Butrón

    Puno, Peru

  • Hospital Regional de Arica

    Arica, Chile

  • Hospital Regional de Concepción,

    Concepción, Chile

  • Hospital Regional de Rancagua

    Rancagua, Chile

  • Hospital Regional de Talca

    Talca, Chile

  • Hospital Regional de Temuco

    Temuco, Chile

  • Hospital San Borja

    Santiago, Chile

  • Hospital San Juan de Dios

    Santiago, Chile

  • Hospital Sótero del Río

    Santiago, Chile

  • Hospital del Norte

    Cochabamba, Bolivia

  • Hospital del Salvador

    Santiago, Chile

  • Instituto Gastroenterológico

    Cochabamba, Bolivia

  • Instituto Nacional de Enfermedades Neoplásicas (INEN)

    Lima, Peru

  • Instituto Oncológico Nacional

    Cochabamba, Bolivia

  • Instituto Regional de Enfermedades Neoplásicas del Norte (IREN Norte)

    Trujillo, Peru

  • Instituto Regional de Enfermedades Neoplásicas del Sur (IREN Sur)

    Arequipa, Peru

  • Statistical Genetics Research Group, Institute of Medical Biometry, University of Heidelberg

    Heidelberg, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.